R&D | March 19, 2026
IIT Roorkee unveils cutting-edge molecular medicine facility
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
Marks significant milestone for breakthrough biologic to treat rare blood cancers
The MAST trial is designed to test whether a single dose of pre-emptive, orally administered EBX-102-02 can protect and restore microbial diversity during transplantation
Phase I EPRAD study of DT-9081 demonstrated a favorable safety profile
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
Huwel’s diagnostic solutions leverage open RT-PCR system
The interim results of the Phase 3 SUCCESSOR-2 study's safety profile aligned with expectations for both mezigdomide and the combination regimen
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
Subscribe To Our Newsletter & Stay Updated
